MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab

Journal of Translational Medicine

Poster Presentation

Zip Feng¹  Carlo Bifulco¹  Bernard A Fox¹  Gennaro Ciliberto²  Paolo A Ascierto²  Marilena Capone²  Marcello Curvietto²  Ester Simeone²  Gerardo Botti²  Gabriele Madonna²  Nicola Mozzillo² 

[1] Earle A. Chiles Research Institute – Providence Cancer Center, Portland, OR, USA;Istituto Nazionale Tumori Fondazione “G. Pascale”, Napoli, Italy;

关键词: Melanoma;    Metastatic Melanoma;    Melanoma Patient;    Ipilimumab;    Host Immune System;   

DOI  :  10.1186/1479-5876-12-S1-P11

来源: Springer

【 授权许可】

CC BY   
© Bifulco et al; licensee BioMed Central Ltd. 2014